VOLITIONRX LTD — Director's Dealing 2015

Dec 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-12-14

Reporting Person: Faulkes Martin Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-14	Common Stock	X	250000	$1.05	Acquired	1291067	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-14	Warrant (Right to Buy)	$1.05	X	250000	Disposed	2016-07-13	Common Stock (250000)	Direct